Study of Arimoclomol in Inclusion Body Myositis (IBM)

Condition:   Inclusion Body MyositisInterventions:   Drug: Arimoclomol;   Other: PlaceboSponsors:   University of Kansas Medical Center;   FDA Office of Orphan Products DevelopmentNot yet recruiting - verified April 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials